Business
Merck drug less effective against moderate COVID -India regulatory source – Reuters
Merck & Co’s (MRK.N) experimental antiviral drug molnupiravir has not shown “significant efficacy” against moderate COVID-19,…
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermidNEW DELHI, Oct 8 (Reuters) – Merck & Co’s (MRK.N) experimental antiviral drug molnupiravir has not shown “significant efficacy”…
Continue Reading
-
Noosa News17 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business21 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
General15 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse
-
Noosa News19 hours agoAnother whale calf caught in Noosa nets